Retinopathy of prematurity (ROP) is one of the most common causes of severe visual impairment and blindness in children worldwide. Because the blood vessels in the retina are not fully developed, ...
Swedish researchers find that daily cortisone eye drops reduce the chance that babies with ROP will require further invasive interventions ...
DelSiTech Ltd. today announced an exclusive licensing agreement pertaining to the development of controlled-release dexamethasone eye drops utilizing DelSiTech™ Silica Matrix technology. Dexamethasone ...
Optifye Therapeutics has struck a deal with DelSiTech for controlled-release dexamethasone eye drops. The exclusive license agreement covers a candidate that uses DelSiTech Silica Matrix technology to ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. PARK CITY, Utah — Stage one of the phase 3 DIAMOND trial ...
Lotta Gränse, ophthalmologist and researcher Lund University and Skåne University Hospital has demonstrated that eye drops containing cortisone can ...
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix, Inc. (Nasdaq: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results